Report Detail

Pharma & Healthcare Global Methotrexate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM2772684
  • |
  • 11 January, 2024
  • |
  • Global
  • |
  • 92 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Methotrexate market size was valued at USD 532.2 million in 2023 and is forecast to a readjusted size of USD 636.2 million by 2030 with a CAGR of 2.6% during review period.
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
The Global Info Research report includes an overview of the development of the Methotrexate industry chain, the market status of Used for Cancers (Methotrexate for Injection, Methotrexate Tablets), Used for Rheumatoid Arthritis (Methotrexate for Injection, Methotrexate Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Methotrexate.
Regionally, the report analyzes the Methotrexate markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Methotrexate market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Methotrexate market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Methotrexate industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Methotrexate for Injection, Methotrexate Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Methotrexate market.
Regional Analysis: The report involves examining the Methotrexate market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Methotrexate market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Methotrexate:
Company Analysis: Report covers individual Methotrexate manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Methotrexate This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Used for Cancers, Used for Rheumatoid Arthritis).
Technology Analysis: Report covers specific technologies relevant to Methotrexate. It assesses the current state, advancements, and potential future developments in Methotrexate areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Methotrexate market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Methotrexate market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Methotrexate for Injection
Methotrexate Tablets
Market segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Major players covered
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Methotrexate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Methotrexate, with price, sales, revenue and global market share of Methotrexate from 2019 to 2024.
Chapter 3, the Methotrexate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Methotrexate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Methotrexate market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Methotrexate.
Chapter 14 and 15, to describe Methotrexate sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Methotrexate
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Methotrexate Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Methotrexate for Injection
    • 1.3.3 Methotrexate Tablets
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Methotrexate Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Used for Cancers
    • 1.4.3 Used for Rheumatoid Arthritis
    • 1.4.4 Used for Other Diseases
  • 1.5 Global Methotrexate Market Size & Forecast
    • 1.5.1 Global Methotrexate Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Methotrexate Sales Quantity (2019-2030)
    • 1.5.3 Global Methotrexate Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Teva Pharmaceutical Industries
    • 2.1.1 Teva Pharmaceutical Industries Details
    • 2.1.2 Teva Pharmaceutical Industries Major Business
    • 2.1.3 Teva Pharmaceutical Industries Methotrexate Product and Services
    • 2.1.4 Teva Pharmaceutical Industries Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Teva Pharmaceutical Industries Recent Developments/Updates
  • 2.2 Qualitestrx (DAVA Pharmaceuticals)
    • 2.2.1 Qualitestrx (DAVA Pharmaceuticals) Details
    • 2.2.2 Qualitestrx (DAVA Pharmaceuticals) Major Business
    • 2.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product and Services
    • 2.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments/Updates
  • 2.3 Pfizer (Hospira)
    • 2.3.1 Pfizer (Hospira) Details
    • 2.3.2 Pfizer (Hospira) Major Business
    • 2.3.3 Pfizer (Hospira) Methotrexate Product and Services
    • 2.3.4 Pfizer (Hospira) Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer (Hospira) Recent Developments/Updates
  • 2.4 Roxane Laboratories
    • 2.4.1 Roxane Laboratories Details
    • 2.4.2 Roxane Laboratories Major Business
    • 2.4.3 Roxane Laboratories Methotrexate Product and Services
    • 2.4.4 Roxane Laboratories Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Roxane Laboratories Recent Developments/Updates
  • 2.5 Sine
    • 2.5.1 Sine Details
    • 2.5.2 Sine Major Business
    • 2.5.3 Sine Methotrexate Product and Services
    • 2.5.4 Sine Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sine Recent Developments/Updates
  • 2.6 Maoxiang
    • 2.6.1 Maoxiang Details
    • 2.6.2 Maoxiang Major Business
    • 2.6.3 Maoxiang Methotrexate Product and Services
    • 2.6.4 Maoxiang Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Maoxiang Recent Developments/Updates
  • 2.7 LingNan Pharmaceutical
    • 2.7.1 LingNan Pharmaceutical Details
    • 2.7.2 LingNan Pharmaceutical Major Business
    • 2.7.3 LingNan Pharmaceutical Methotrexate Product and Services
    • 2.7.4 LingNan Pharmaceutical Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 LingNan Pharmaceutical Recent Developments/Updates
  • 2.8 Powerdone
    • 2.8.1 Powerdone Details
    • 2.8.2 Powerdone Major Business
    • 2.8.3 Powerdone Methotrexate Product and Services
    • 2.8.4 Powerdone Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Powerdone Recent Developments/Updates
  • 2.9 Huiyu
    • 2.9.1 Huiyu Details
    • 2.9.2 Huiyu Major Business
    • 2.9.3 Huiyu Methotrexate Product and Services
    • 2.9.4 Huiyu Methotrexate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Huiyu Recent Developments/Updates

3 Competitive Environment: Methotrexate by Manufacturer

  • 3.1 Global Methotrexate Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Methotrexate Revenue by Manufacturer (2019-2024)
  • 3.3 Global Methotrexate Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Methotrexate by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Methotrexate Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Methotrexate Manufacturer Market Share in 2023
  • 3.5 Methotrexate Market: Overall Company Footprint Analysis
    • 3.5.1 Methotrexate Market: Region Footprint
    • 3.5.2 Methotrexate Market: Company Product Type Footprint
    • 3.5.3 Methotrexate Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Methotrexate Market Size by Region
    • 4.1.1 Global Methotrexate Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Methotrexate Consumption Value by Region (2019-2030)
    • 4.1.3 Global Methotrexate Average Price by Region (2019-2030)
  • 4.2 North America Methotrexate Consumption Value (2019-2030)
  • 4.3 Europe Methotrexate Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Methotrexate Consumption Value (2019-2030)
  • 4.5 South America Methotrexate Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Methotrexate Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Methotrexate Sales Quantity by Type (2019-2030)
  • 5.2 Global Methotrexate Consumption Value by Type (2019-2030)
  • 5.3 Global Methotrexate Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Methotrexate Sales Quantity by Application (2019-2030)
  • 6.2 Global Methotrexate Consumption Value by Application (2019-2030)
  • 6.3 Global Methotrexate Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Methotrexate Sales Quantity by Type (2019-2030)
  • 7.2 North America Methotrexate Sales Quantity by Application (2019-2030)
  • 7.3 North America Methotrexate Market Size by Country
    • 7.3.1 North America Methotrexate Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Methotrexate Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Methotrexate Sales Quantity by Type (2019-2030)
  • 8.2 Europe Methotrexate Sales Quantity by Application (2019-2030)
  • 8.3 Europe Methotrexate Market Size by Country
    • 8.3.1 Europe Methotrexate Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Methotrexate Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Methotrexate Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Methotrexate Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Methotrexate Market Size by Region
    • 9.3.1 Asia-Pacific Methotrexate Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Methotrexate Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Methotrexate Sales Quantity by Type (2019-2030)
  • 10.2 South America Methotrexate Sales Quantity by Application (2019-2030)
  • 10.3 South America Methotrexate Market Size by Country
    • 10.3.1 South America Methotrexate Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Methotrexate Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Methotrexate Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Methotrexate Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Methotrexate Market Size by Country
    • 11.3.1 Middle East & Africa Methotrexate Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Methotrexate Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Methotrexate Market Drivers
  • 12.2 Methotrexate Market Restraints
  • 12.3 Methotrexate Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Methotrexate and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Methotrexate
  • 13.3 Methotrexate Production Process
  • 13.4 Methotrexate Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Methotrexate Typical Distributors
  • 14.3 Methotrexate Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Methotrexate . Industry analysis & Market Report on Methotrexate is a syndicated market report, published as Global Methotrexate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Methotrexate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,777.04
    4,165.56
    5,554.08
    3,250.32
    4,875.48
    6,500.64
    543,819.60
    815,729.40
    1,087,639.20
    290,545.20
    435,817.80
    581,090.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report